Study of Individuals and Families at High Risk for Blood Cancers
Name of the Study
Why Is This Study Important?
Researchers want to study individuals and families who may have a genetic predisposition to developing hematologic cancers. Studying this population may help identify other persons at risk, precursor conditions, clues to etiology, and the genes involved in these malignancies.
"We have compared DNA from family members affected by chronic lymphocytic leukemia (CLL) with those family members not affected by CLL through linkage analysis," said Dr. Caporaso. "This allows us to identify areas of the DNA that may harbor a gene or genes responsible for causing the disease."
"We are also recruiting families having more than one member diagnosed with Waldenstrom's macroglobulinemia, Hodgkin's lymphoma, and non-Hodgkin's lymphoma so that we can conduct analyses to identify genes that may predispose people to these cancers," said Dr. McMaster.
Who Can Join This Study?
Where Is This Study Taking Place?
Who to Contact
An archive of "Featured Clinical Trial" columns is available at http://cancer.gov/clinicaltrials/ft-all-featured-trials.